Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

REVEALED: 2 | Vintage Vibes

Hackers join U.S. and Israel's fight with Iran

A cyberattack this week allegedly linked to Iran‑aligned hackers disrupted operations at U.S. medical technology company Stryker.

Axios

US medical equipment company Stryker says cyberattack disrupted its global networks.

Stryker, a U.S. medical equipment company, says a cyberattack has disrupted its global networks

The Independent UK

Pro-Iran hackers hit US medical device giant Stryker in shocking cyberattack after Israel strikes

Iran vs US-Israel war: A major US medical device maker, Stryker, has recently faced a cyberattack and investigators are linking it to pro-Iranian hackers amid geopolitical tensions. The incident signals healthcare companies are now strategic targets in global cyber conflicts. Experts warn of disruptions affecting patient care. The attack underscores…

The Times of India

From analysis to the latest developments in health,
read the most diverse news in one place.

How Is Stryker's Stock Performance Compared to Other Healthcare Stocks?

Despite Stryker’s underperformance relative to its peers over the past year, Wall Street analysts remain moderately optimistic about the stock’s prospects.

Barchart

Stryker Earnings Preview: What to Expect

Stryker is set to report its fourth-quarter earnings next month, with Wall Street expecting high single-digit growth in the bottom line.

Barchart

3 Healthcare Giants Just Raised Dividends—Here’s Who Pays the Most

Healthcare behemoths, including the biggest name of them all, are increasing their dividends. Additionally, AMGN's dividend yield now sits solidly above 3%.

MarketBeat

Stryker Stock: Is SYK Underperforming the Healthcare Sector?

Healthcare giant Stryker has notably underperformed the broader market over the past year, yet analysts remain optimistic about the stock’s prospects.

Barchart

Read news from The Economist, FT, and more,
with one subscription

Beware the Death Cross: 3 Stocks Triggering This Spooky Signal

The Death Cross is something you never want to see on a stock you own. Take caution with these three companies that recently were visited by this scary signal.

MarketBeat

What You Need to Know Ahead of Stryker's Earnings Release

Stryker will release its third-quarter earnings later this month, and analysts anticipate a high single-digit bottom-line growth.

Barchart

Is Stryker Stock Underperforming the Dow?

Stryker has underperformed the Dow over the past year, but analysts are cautiously optimistic about the stock’s prospects.

Barchart

Stryker Stock: Is Wall Street Bullish or Bearish?

Though Stryker has underperformed the SPX over the past year, Wall Street analysts maintain a moderately optimistic outlook on the stock’s prospects.

Barchart

Is Stryker Stock Underperforming the Nasdaq?

Although Stryker has slightly underperformed the Nasdaq over the past year, its fundamentals have remained strong, and analysts remain strongly bullish on the stock’s prospects.

Barchart

Stryker Stock: Analyst Estimates & Ratings

Stryker has outperformed the broader market over the past year, Wall Street analysts remain highly bullish about the stock's prospects.

Barchart

‘Like driving through the fog’: CEOs discuss how to handle the 90-day pause in the tariff war

Trump launches a new attack on the Fed’s Powell, the Qatar jet issue is not going away.

Fortune

Get all your
news in one place.

100's of premium titles.
One news app.

MarketBeat

If You Could Only Hold 3 Investments for Life, Consider These

Discover 3 must-own investments for lifelong growth. From dividend stocks to a market-beating ETF, these picks offer stability, returns, and long-term wealth.

Barchart

Is Stryker Stock Outperforming the S&P 500?

Stryker has outperformed the S&P 500 recently, and analysts remain highly optimistic about the stock’s prospects.

Barchart

Do Wall Street Analysts Like Stryker Stock?

Although Stryker has lagged behind the S&P 500 Index over the past year, Wall Street analysts remain strongly optimistic about the stock's prospects.

Barchart

Stocks Steady Before the Open After Tech-Fueled Selloff, FOMC Meeting on Tap

March S&P 500 E-Mini futures (ESH25) are up +0.09%, and March Nasdaq 100 E-Mini futures (NQH25) are up +0.16% this morning, stabilizing after yesterday’s dramatic selloff, while investors awaited the start of the Federal Reserve’s two-day policy meeting as well as a flurry of U.S. economic data and corporate earnings…

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

S&P Futures Gain Ahead of FOMC Meeting, U.S. Economic Data and Earnings on Tap

March S&P 500 E-Mini futures (ESH25) are trending up +0.42% this morning, partially rebounding from yesterday’s dramatic selloff, while investors awaited the start of the Federal Reserve’s two-day policy meeting as well as a flurry of U.S. economic data and corporate earnings reports.

Barchart

Earnings Preview: What to Expect from Stryker’s Report

With Stryker gearing up to release its fourth-quarter earnings later this month, analysts expect a significant double-digit growth in earnings.

MarketBeat

3 Stocks Helping to Bring AI to Healthcare

Many profitable companies are using AI to make healthcare more efficient; and these companies are rewarding investors with share price growth and dividends

Barchart

3 MedTech Stocks to Grab Now for a Strong 2025

This article highlights three MedTech stocks poised for growth in 2025

Barchart

How Is Stryker's Stock Performance Compared to Other Medical Device Stocks?

Stryker has substantially outpaced other medical device stocks over the past year and analysts remain strongly bullish on the stock’s prospects.

Benzinga

Cracking The Code: Understanding Analyst Reviews For Stryker

Ratings for Stryker (NYSE:SYK) were provided by 19 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.

Barchart

Stryker Stock Outlook: Is Wall Street Bullish or Bearish?

Medtech giant Stryker has outperformed the broader market over the past year, and analysts remain moderately bullish on the stock’s prospects.

1 2 3 4

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.